What are Bruton tyrosine kinase inhibitors and why are they revolutionizing cancer therapy? In the evolving field of oncology, precision medicine is no longer just a future goal—it’s happening now. One of the most promising categories in targeted cancer treatment is Bruton tyrosine kinase (BTK) inhibitors. These small molecule drugs work by blocking BTK, a key enzyme in the B-cell...